Hospitalisations due to respiratory syncytial virus infection in children with Down syndrome before and after palivizumab recommendation in Japan.
Keisuke OkamotoTomohiro MorioYoshikazu NakamuraHiroshi HatayaKoichi MizutaMasaaki MoriPublished in: Acta paediatrica (Oslo, Norway : 1992) (2020)
The cumulative RSVH rate tended to be decreased after approval for all children with Down syndrome although the result was not significant.
Keyphrases